House Sponsors: O'BRIEN-FEIGENHOLTZ-CROTTY-KLINGLER-CURRY,JULIE AND MCGUIRE. Senate Sponsors: SYVERSON-PARKER-MOLARO-LIGHTFORD-MUNOZ Short description: GENERIC BRAND DRUGS Synopsis of Bill as introduced: Amends the Pharmacy Practice Act and the Illinois Food, Drug and Cosmetic Act. Provides that pharmacists may substitute generic brand drugs, provided that the selected drug has been rated therapeutically equivalent to the prescribed drug in the Orange book or meets other specified criteria. Effective immediately. HOUSE AMENDMENT NO. 1. Replaces everything after the enacting clause. Amends the Pharmacy Practice Act of 1987 and the Illinois Food, Drug, and Cosmetic Act to make technical changes. HOUSE AMENDMENT NO. 2. Replaces everything after the enacting clause. Amends the Pharmacy Practice Act of 1987 and the Illinois Food, Drug and Cosmetic Act. Provides that a generic drug determined to be therapeutically equivalent by the United States Food and Drug Administration (FDA) shall be available for substitution in Illinois, provided that each manufacturer submits a notification containing product technical bioequivalence information as a prerequisite to product substitution. Provides that, if the Technical Advisory Council finds that a generic drug product may have issues related to the practice of medicine or the practice of pharmacy, the Technical Advisory Council shall hold a hearing. Provides that a decision to prohibit a generic drug from substitution must be accompanied by a written detailed explanation of the basis for the decision. Provides that drug products previously approved by the Technical Advisory Council for generic interchange may be substituted in the State of Illinois without further review under specified circumstances. Provides an immediate effective date for the sole purpose of allowing the Department of Public Health to begin rulemaking, otherwise effective on September 1, 2000. Last action on Bill: PUBLIC ACT.............................. 91-0766 Last action date: 00-06-09 Location: House Amendments to Bill: AMENDMENTS ADOPTED: HOUSE - 2 SENATE - 0 END OF INQUIRY Full Text Bill Status